Eli Lilly, announced an investment exceeding $1 billion to establish new contract manufacturing operations in India. Central to this initiative is the development of a major manufacturing and quality facility in Hyderabad, Telangana. This multi-year investment represents one of the most significant commitments by a global drug maker in India...
SSi Mantra 3 Robotic Device Used in Cardiac Surgery
SS Innovations International, a Fort Lauderdale, Florida- based medtech firm with offices in Gurgaon, India marked a milestone with its SSi Mantra 3 robotic surgery system being used for the first time in the Western Hemisphere to perform cardiac surgery. On June 8, Dr. Juan Zuniga at Interhospital in Guayaquil,...
Pepsico Harnesses India Tech Talent to Leverage GenAI
PepsiCo is aggressively adopting generative artificial intelligence (GenAI) technology to accelerate its product development and launch timelines, according to Chief Strategy and Transformation Officer Athina Kanioura. The company behind brands such as Pepsi, Tropicana, and Lays is leveraging GenAI across areas such as productivity, marketing, customer service, and feedback analysis...
KKR: Asia’s Edge Lies in Industrial Services
New York-based Henry H. McVey,and Singapore-based Frances Lim, both KKR’s heads of global and Asia macro, said in an October note that Asia’s competitive advantage used to be inexpensive labor. Now, whether it’s China, India, or Japan, the region’s edge lies in industrial services. "The bid for infrastructure and logistics...
HP Enterprise, VVDN Tech, to Manufacture $1Billion Worth of Servers in 4-5 years
Palo Alto CA-headquartered Hewlett Packard Enterprise (HPE) and original design equipment maker VVDN Technologies headquartered both in Gurugram, India, and Fremont, CA, signed a pact to produce high-end servers worth $1 billion in the next five years. The production is expected to start from November this year. India recently announced...
India’s Startup Develops AI-Based Blood Test to Identify Tumors Early
Gurugram-based startup PredOmix has created a blood test that can identify 32 malignancies with 98 percent accuracy in both men and women. The business' patented OncoVeryx-F technology combines metabolomics (the study of tiny molecules) with Artificial Intelligence to detect metabolite fingerprints in a single test. Dr. Kanury V.S. Rao, co-founder...